- Home
- EDIT vs HQI Comparison
EDIT vs HQI Comparison
Compare EDIT & HQI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | EDIT | HQI |
|---|---|---|
| Founded | 2013 | 2002 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Biotechnology: Biological Products (No Diagnostic Substances) | Professional Services |
| Sector | Health Care | Consumer Discretionary |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 233.3M | 128.5M |
| IPO Year | 2016 | N/A |
Fundamental Metrics
Financial Performance| Metric | EDIT | HQI |
|---|---|---|
| Price | $2.54 | $7.97 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 10 | 1 |
| Target Price | $4.13 | ★ $13.00 |
| AVG Volume (30 Days) | ★ 1.6M | 32.9K |
| Earning Date | 11-10-2025 | 11-06-2025 |
| Dividend Yield | N/A | ★ 3.04% |
| EPS Growth | N/A | ★ 412.84 |
| EPS | N/A | ★ 0.50 |
| Revenue | ★ $46,383,000.00 | $31,691,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | $1.17 |
| P/E Ratio | ★ N/A | $15.20 |
| Revenue Growth | N/A | ★ N/A |
| 52 Week Low | $0.91 | $7.52 |
| 52 Week High | $4.54 | $15.75 |
Technical Indicators
Market Signals| Indicator | EDIT | HQI |
|---|---|---|
| Relative Strength Index (RSI) | 48.30 | 43.19 |
| Support Level | $2.09 | $7.52 |
| Resistance Level | $2.70 | $8.36 |
| Average True Range (ATR) | 0.16 | 0.60 |
| MACD | 0.06 | -0.06 |
| Stochastic Oscillator | 75.41 | 26.63 |
Price Performance
Historical ComparisonAbout EDIT Editas Medicine Inc.
Editas Medicine Inc is a clinical-stage genome editing company dedicated to developing potentially transformative genomic medicines to treat a broad range of serious diseases. The company focuses on developing a proprietary genome editing platform based on clustered, regularly interspaced short palindromic repeats (CRISPR)/ CRISPR-associated protein 9 (Cas9 technology). It has developed CRISPR/Cas9 technology which uses a protein-RNA (ribonucleic acid) complex composed of the Cas9 enzyme bound to a guide RNA molecule designed to recognize a DNA (deoxyribonucleic acid) sequence that requires repair. The company is engaged in developing and commercializing genome editing technology.
About HQI HireQuest Inc. (DE)
HireQuest Inc is a nationwide franchisor of offices providing direct-dispatch, executive search, and commercial staffing solutions in the light industrial and blue-collar segments of the staffing industry and traditional commercial staffing. The company's franchisees provide various types of temporary personnel through two business models operating under the trade names HireQuest Direct, HireQuest, Snelling, DriverQuest, HireQuest Health, Northbound Executive Search, and MRI. The company's primary source of revenue is royalty fees based on the operation of its franchised offices.